COVID-19 has become the most researched disease outbreak in history. Evidence on the financing, costs and impact of COVID-19 is critical in supporting countries across the world in planning their COVID-19 response.
We have built C19economics.org as a platform to enable, improve and share health economics evidence to inform COVID-related decision making and policies globally, with a focus on low and middle income countries (LMICs).
Pressing need to make policy decisions quickly
especially in low and middle income countries, where health systems and governance may be fragile.
Need for peer learning and support
for analysts working to provide policy makers with health economics evidence
Restrictions in travel
limiting the possibilities to meet and share evidence and research in person
Current lack of a platform
for health economics which connects researchers and decision-makers
We are a community of academics, practitioners and external partners supporting countries in their COVID-19 response.
We created the C19Economics.org to curate experiences, data, tools and analyses and support health economists to generate evidence for policy across LMIC settings in a demand driven and scientifically robust fashion.
Our goal is to facilitate the sharing of experiences and provide analysts with access to a focused set of resources, and a space to informally receive peer support and review, given the pressures to produce rapid results in an emerging field.
We also aim to provide decision makers with a space to access analyses and summaries of relevant evidence as it emerges directly to shape national and regional decision making.
Who we are
This platform has been funded by the Bill and Melinda Gates Foundation, Wellcome Trust, UK Foreign Commonwealth and Development Office and is supported by the London School of Hygiene and Tropical Medicine and the International Decision Support Initiative (Center for Global Development, HITAP)